CHB Investment Group LLC Buys New Shares in The Allstate Co. (NYSE:ALL)

CHB Investment Group LLC acquired a new stake in shares of The Allstate Co. (NYSE:ALL) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 15,997 shares of the insurance provider’s stock, valued at approximately $3,034,000. Allstate accounts for 1.6% of CHB Investment Group LLC’s investment portfolio, making the stock its 17th largest holding.

Other institutional investors have also recently made changes to their positions in the company. Rise Advisors LLC acquired a new stake in shares of Allstate in the 1st quarter worth about $26,000. Northwest Investment Counselors LLC bought a new stake in Allstate in the 1st quarter worth about $26,000. Versant Capital Management Inc grew its position in Allstate by 70.9% in the 2nd quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock worth $30,000 after purchasing an additional 78 shares in the last quarter. Family Firm Inc. bought a new stake in Allstate in the 2nd quarter worth about $38,000. Finally, MCF Advisors LLC grew its position in Allstate by 33.9% in the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after purchasing an additional 84 shares in the last quarter. Institutional investors and hedge funds own 76.47% of the company’s stock.

Insider Activity at Allstate

In other Allstate news, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares of the company’s stock, valued at $5,236,922.32. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. In other Allstate news, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares of the company’s stock, valued at $5,236,922.32. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO Thomas J. Wilson sold 90,000 shares of Allstate stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the completion of the transaction, the chief executive officer now directly owns 88,552 shares of the company’s stock, valued at $15,880,915.68. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 192,530 shares of company stock valued at $34,967,665. Corporate insiders own 1.80% of the company’s stock.

Allstate Trading Down 0.7 %

NYSE:ALL opened at $194.14 on Friday. The company’s 50 day moving average price is $186.17 and its 200-day moving average price is $173.64. The Allstate Co. has a 52 week low of $121.70 and a 52 week high of $198.79. The company has a quick ratio of 0.36, a current ratio of 0.36 and a debt-to-equity ratio of 0.49. The stock has a market cap of $51.24 billion, a price-to-earnings ratio of 43.16, a PEG ratio of 1.74 and a beta of 0.48.

Allstate (NYSE:ALL) last released its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $1.61 earnings per share for the quarter, topping the consensus estimate of $0.33 by $1.28. Allstate had a net margin of 5.03% and a return on equity of 24.05%. The business had revenue of $15.71 billion for the quarter, compared to the consensus estimate of $14.04 billion. During the same period last year, the firm earned ($4.42) earnings per share. The company’s quarterly revenue was up 12.4% on a year-over-year basis. On average, equities research analysts forecast that The Allstate Co. will post 15.19 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on ALL shares. UBS Group lifted their price target on shares of Allstate from $215.00 to $216.00 and gave the stock a “buy” rating in a report on Tuesday. Jefferies Financial Group boosted their price target on shares of Allstate from $217.00 to $231.00 and gave the company a “buy” rating in a research report on Wednesday, October 9th. Piper Sandler boosted their price target on shares of Allstate from $188.00 to $196.00 and gave the company an “overweight” rating in a research report on Friday, August 16th. Roth Mkm restated a “buy” rating and set a $200.00 price target on shares of Allstate in a research report on Wednesday, August 14th. Finally, Raymond James boosted their price target on shares of Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a research report on Friday, October 4th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $201.06.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.